中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/21 | 6,752 | 6,967 | 6,752 | 6,876 | +140 | +2.1% | 3,373,300 |
| 2025/03/19 | 6,820 | 6,860 | 6,731 | 6,736 | -93 | -1.4% | 2,303,900 |
| 2025/03/18 | 6,931 | 6,962 | 6,809 | 6,829 | -33 | -0.5% | 2,250,600 |
| 2025/03/17 | 6,981 | 6,996 | 6,862 | 6,862 | -19 | -0.3% | 1,208,400 |
| 2025/03/14 | 6,803 | 6,956 | 6,757 | 6,881 | +4 | +0.1% | 3,223,200 |
| 2025/03/13 | 6,956 | 7,047 | 6,877 | 6,877 | -61 | -0.9% | 2,408,600 |
| 2025/03/12 | 6,814 | 7,038 | 6,814 | 6,938 | +153 | +2.3% | 2,604,600 |
| 2025/03/11 | 6,511 | 6,801 | 6,472 | 6,785 | +78 | +1.2% | 3,277,600 |
| 2025/03/10 | 6,924 | 6,967 | 6,666 | 6,707 | -256 | -3.7% | 2,700,800 |
| 2025/03/07 | 7,071 | 7,112 | 6,911 | 6,963 | -389 | -5.3% | 3,187,300 |
| 2025/03/06 | 7,423 | 7,492 | 7,352 | 7,352 | -158 | -2.1% | 1,896,400 |
| 2025/03/05 | 7,418 | 7,553 | 7,338 | 7,510 | +83 | +1.1% | 1,727,300 |
| 2025/03/04 | 7,581 | 7,618 | 7,382 | 7,427 | -194 | -2.5% | 3,104,300 |
| 2025/03/03 | 7,787 | 7,787 | 7,606 | 7,621 | +134 | +1.8% | 1,813,200 |
| 2025/02/28 | 7,555 | 7,702 | 7,456 | 7,487 | -201 | -2.6% | 3,812,100 |
| 2025/02/27 | 7,916 | 7,949 | 7,664 | 7,688 | -210 | -2.7% | 2,475,400 |
| 2025/02/26 | 7,900 | 7,979 | 7,820 | 7,898 | +32 | +0.4% | 2,509,600 |
| 2025/02/25 | 7,710 | 7,895 | 7,710 | 7,866 | +181 | +2.4% | 3,071,400 |
| 2025/02/21 | 7,500 | 7,705 | 7,484 | 7,685 | +329 | +4.5% | 3,520,300 |
| 2025/02/20 | 7,307 | 7,356 | 7,146 | 7,356 | -44 | -0.6% | 1,851,200 |
| 2025/02/19 | 7,385 | 7,410 | 7,300 | 7,400 | -4 | -0.1% | 1,366,100 |
| 2025/02/18 | 7,350 | 7,423 | 7,217 | 7,404 | +17 | +0.2% | 1,315,100 |
| 2025/02/17 | 7,297 | 7,418 | 7,273 | 7,387 | +136 | +1.9% | 1,359,500 |
| 2025/02/14 | 7,216 | 7,266 | 7,190 | 7,251 | -4 | -0.1% | 2,066,900 |
| 2025/02/13 | 7,075 | 7,284 | 7,054 | 7,255 | +280 | +4% | 1,938,100 |
| 2025/02/12 | 7,030 | 7,084 | 6,939 | 6,975 | -5 | -0.1% | 2,670,500 |
| 2025/02/10 | 6,909 | 6,995 | 6,851 | 6,980 | +58 | +0.8% | 1,765,200 |
| 2025/02/07 | 6,839 | 6,941 | 6,764 | 6,922 | +167 | +2.5% | 2,438,600 |
| 2025/02/06 | 6,724 | 6,938 | 6,700 | 6,755 | +130 | +2% | 2,315,600 |
| 2025/02/05 | 6,653 | 6,713 | 6,589 | 6,625 | -28 | -0.4% | 1,394,300 |
| 2025/02/04 | 6,820 | 6,858 | 6,589 | 6,653 | -47 | -0.7% | 1,767,200 |
| 2025/02/03 | 6,594 | 6,822 | 6,517 | 6,700 | -34 | -0.5% | 2,719,900 |
| 2025/01/31 | 6,566 | 6,809 | 6,489 | 6,734 | +368 | +5.8% | 4,183,500 |
| 2025/01/30 | 6,436 | 6,471 | 6,288 | 6,366 | -14 | -0.2% | 1,871,600 |
| 2025/01/29 | 6,399 | 6,472 | 6,357 | 6,380 | -14 | -0.2% | 1,702,900 |
| 2025/01/28 | 6,471 | 6,485 | 6,378 | 6,394 | -78 | -1.2% | 1,801,000 |
| 2025/01/27 | 6,580 | 6,620 | 6,455 | 6,472 | -31 | -0.5% | 2,296,300 |
| 2025/01/24 | 6,575 | 6,622 | 6,440 | 6,503 | -63 | -1% | 2,285,200 |
| 2025/01/23 | 6,580 | 6,609 | 6,488 | 6,566 | -47 | -0.7% | 1,507,300 |
| 2025/01/22 | 6,674 | 6,714 | 6,588 | 6,613 | +43 | +0.7% | 1,364,700 |
| 2025/01/21 | 6,685 | 6,685 | 6,551 | 6,570 | -120 | -1.8% | 1,125,200 |
| 2025/01/20 | 6,565 | 6,736 | 6,543 | 6,690 | +67 | +1% | 1,745,800 |
| 2025/01/17 | 6,561 | 6,632 | 6,495 | 6,623 | +5 | +0.1% | 1,304,300 |
| 2025/01/16 | 6,780 | 6,785 | 6,608 | 6,618 | -96 | -1.4% | 1,528,000 |
| 2025/01/15 | 6,836 | 6,890 | 6,611 | 6,714 | -86 | -1.3% | 2,116,200 |
| 2025/01/14 | 6,750 | 6,918 | 6,745 | 6,800 | +63 | +0.9% | 2,252,300 |
| 2025/01/10 | 6,836 | 6,887 | 6,582 | 6,737 | -217 | -3.1% | 3,520,500 |
| 2025/01/09 | 6,817 | 6,960 | 6,789 | 6,954 | +237 | +3.5% | 1,814,600 |
| 2025/01/08 | 6,828 | 6,834 | 6,696 | 6,717 | -136 | -2% | 1,903,200 |
| 2025/01/07 | 6,840 | 6,877 | 6,791 | 6,853 | +6 | +0.1% | 1,808,200 |
51～
100
件表示中 / 3713件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 735,600円 | +1.7% | +5.0% | 3.40% | 29.53倍 | 6.37倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 359,200円 | +6.0% | +4.0% | 2.17% | 22.30倍 | 4.12倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 427,000円 | -1.1% | +75.3% | 4.68% | 29.25倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 689,600円 | +2.2% | +10.2% | 1.74% | 13.24倍 | 1.33倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,000円 | +0.9% | +380.2% | 5.61% | 19.14倍 | 1.64倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
